Original Research

Published on 22 Jul 2024

Enhancement of complement-dependent cytotoxicity by linking factor-H derived short consensus repeats 19-20 to CD20 antibodies

in Cancer Immunity and Immunotherapy

Lena Prantl
Philipp Heider
Lisa Bergmeister
Katharina Calana
Jan-Paul Bohn
Dominik Wolf
Zoltan Banki
Andreas Bosch
Maximilian Plach
Georg Huber

Frontiers in Immunology

doi 10.3389/fimmu.2024.1379023

430 views

Original Research

Published on 22 Jul 2024

Advancing bladder cancer management: development of a prognostic model and personalized therapy

in Cancer Immunity and Immunotherapy

Xiang Huang
Guotu Du
Ying Yang
Peng Su
Shicheng Chen
Chongjiong Cai
Tianyu Huang
Yu Zeng
Yonggang Tao
Demei Tian

Frontiers in Immunology

doi 10.3389/fimmu.2024.1430792

399 views

Mini Review

Published on 22 Jul 2024

Targeting mitochondrial damage: shining a new light on immunotherapy

in Cancer Immunity and Immunotherapy

Wenjuan Zeng
Menghui Wang
Yuxin Zhang
Taicheng Zhou
Zhen Zong

Frontiers in Immunology

doi 10.3389/fimmu.2024.1432633

350 views

Review

Published on 19 Jul 2024

The role of innate immune cells in the colorectal cancer tumor microenvironment and advances in anti-tumor therapy research

in Cancer Immunity and Immunotherapy

Wenxuan Liu
Tianrui Kuang
Li Liu
Wenhong Deng

Frontiers in Immunology

doi 10.3389/fimmu.2024.1407449

655 views

Original Research

Published on 19 Jul 2024

Circ_BBS9 as an early diagnostic biomarker for lung adenocarcinoma: direct interaction with IFIT3 in the modulation of tumor immune microenvironment

in Cancer Immunity and Immunotherapy

Daijun Peng
Mingyu Liang
Lingyu Li
Haisheng Yang
Di Fang
Lingling Chen
Bing Guan

Frontiers in Immunology

doi 10.3389/fimmu.2024.1344954

281 views

Original Research

Published on 19 Jul 2024

The profile and prognostic significance of bone marrow T-cell differentiation subsets in adult AML at diagnosis

in Cancer Immunity and Immunotherapy

Kai Sun
Zong-Yan Shi
Ya-Zhe Wang
Dai-Hong Xie
Yan-Rong Liu
Qian Jiang
Hao Jiang
Xiao-Jun Huang
Ya-Zhen Qin

Frontiers in Immunology

doi 10.3389/fimmu.2024.1418792

413 views

Mini Review

Published on 19 Jul 2024

β-glucan: a potent adjuvant in immunotherapy for digestive tract tumors

in Cancer Immunity and Immunotherapy

Meiyu Wang
Jinhua Pan
Wu Xiang
Zilong You
Yue Zhang
Junyu Wang
Anren Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1424261

4,592 views

Systematic Review

Published on 19 Jul 2024

Efficacy and safety of PD-1/L1 inhibitors as first-line therapy for metastatic colorectal cancer: a meta-analysis

in Cancer Immunity and Immunotherapy

Zhilong Huang
Chunyan Li
Yanping Huang
Weiming Liang
Haiyun Tao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1425596

323 views

Review

Published on 19 Jul 2024

Mismatch repair-proficient tumor footprints in the sands of immune desert: mechanistic constraints and precision platforms

in Cancer Immunity and Immunotherapy

Biswanath Majumder
Nishanth Belugali Nataraj
Leela Maitreyi
Santanu Datta

Frontiers in Immunology

doi 10.3389/fimmu.2024.1414376

1,760 views

Original Research

Published on 19 Jul 2024

iPSC-derived NK cells expressing high-affinity IgG Fc receptor fusion CD64/16A to mediate flexible, multi-tumor antigen targeting for lymphoma

in Cancer Immunity and Immunotherapy

Kate J. Dixon
Kristin M. Snyder
Melissa Khaw
Robert Hullsiek
Zachary B. Davis
Anders W. Matson
Soheila Shirinbak
Bryan Hancock
Ryan Bjordahl
Martin Hosking

Frontiers in Immunology

doi 10.3389/fimmu.2024.1407567

735 views

Original Research

Accepted on 18 Jul 2024

The Comprehensive Landscape Analysis of The Autophagy in Cancer Development and Drug Resistance

in Cancer Immunity and Immunotherapy

Yue Li
Yang Yin
Tong Zhang
Jinhua Wang
Yuyun Li
Zeqi Guo
Ya Zhao
Ruihong Qin
Qian He

Frontiers in Immunology

doi 10.3389/fimmu.2024.1412781

Original Research

Accepted on 18 Jul 2024

Good Manufacturing Practice-grade generation of CD19 and CD123-specific CAR-T cells using piggyBac transposon and allogeneic feeder cells in patients diagnosed with B-cell non-Hodgkin lymphoma and acute myeloid leukemia

in Cancer Immunity and Immunotherapy

Martin Mucha
Martin Štach
Iva Kaštánková
Jana Rychlá
Petr Lesný
Pavel Otáhal

Frontiers in Immunology

doi 10.3389/fimmu.2024.1415328

Review

Published on 18 Jul 2024

A future directions of renal cell carcinoma treatment: combination of immune checkpoint inhibition and carbon ion radiotherapy

in Cancer Immunity and Immunotherapy

Zhouhang Zheng
Tianci Yang
Yixuan Li
Pei Qu
Zhiang Shao
Yuan Wang
Wei Chang
Shahzad Muhammad Umar
Jufang Wang
Nan Ding

Frontiers in Immunology

doi 10.3389/fimmu.2024.1428584

466 views

Correction

Published on 18 Jul 2024

Corrigendum: Ex vivo modulation of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytes

in Cancer Immunity and Immunotherapy

Thomas Morgan Hulen
Christina Friese
Nikolaj Pagh Kristensen
Joachim Stoltenborg Granhøj
Troels Holz Borch
Marlies J. W. Peeters
Marco Donia
Mads Hald Andersen
Sine Reker Hadrup
Inge Marie Svane

Frontiers in Immunology

doi 10.3389/fimmu.2024.1462081

194 views

Review

Published on 18 Jul 2024

CAR-T lymphocyte-based cell therapies; mechanistic substantiation, applications and biosafety enhancement with suicide genes: new opportunities to melt side effects

in Cancer Immunity and Immunotherapy

Paula Ercilla-Rodríguez
Marta Sánchez-Díez
Nicolás Alegría-Aravena
Josefa Quiroz-Troncoso
Clara E. Gavira-O'Neill
Raquel González-Martos
Carmen Ramírez-Castillejo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1333150

861 views

Original Research

Published on 18 Jul 2024

A disulfidptosis-related glucose metabolism and immune response prognostic model revealing the immune microenvironment in lung adenocarcinoma

in Cancer Immunity and Immunotherapy

Kai Zhang
Gang Li
Qin Wang
Xin Liu
Hong Chen
Fuqiang Li
Shuangyan Li
Xinmao Song
Yi Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1398802

445 views

Navigation group

Articles

Enhancement of complement-dependent cytotoxicity by linking factor-H derived short consensus repeats 19-20 to CD20 antibodies

Advancing bladder cancer management: development of a prognostic model and personalized therapy

Targeting mitochondrial damage: shining a new light on immunotherapy

The role of innate immune cells in the colorectal cancer tumor microenvironment and advances in anti-tumor therapy research

Circ_BBS9 as an early diagnostic biomarker for lung adenocarcinoma: direct interaction with IFIT3 in the modulation of tumor immune microenvironment

The profile and prognostic significance of bone marrow T-cell differentiation subsets in adult AML at diagnosis

β-glucan: a potent adjuvant in immunotherapy for digestive tract tumors

Efficacy and safety of PD-1/L1 inhibitors as first-line therapy for metastatic colorectal cancer: a meta-analysis

Mismatch repair-proficient tumor footprints in the sands of immune desert: mechanistic constraints and precision platforms

iPSC-derived NK cells expressing high-affinity IgG Fc receptor fusion CD64/16A to mediate flexible, multi-tumor antigen targeting for lymphoma

The Comprehensive Landscape Analysis of The Autophagy in Cancer Development and Drug Resistance

Good Manufacturing Practice-grade generation of CD19 and CD123-specific CAR-T cells using piggyBac transposon and allogeneic feeder cells in patients diagnosed with B-cell non-Hodgkin lymphoma and acute myeloid leukemia

A future directions of renal cell carcinoma treatment: combination of immune checkpoint inhibition and carbon ion radiotherapy

Corrigendum: Ex vivo modulation of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytes

CAR-T lymphocyte-based cell therapies; mechanistic substantiation, applications and biosafety enhancement with suicide genes: new opportunities to melt side effects

A disulfidptosis-related glucose metabolism and immune response prognostic model revealing the immune microenvironment in lung adenocarcinoma